N

Neurocrine Biosciences

1239 employees

Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.

Investor insights

Sectors invested in

Health Care2
Genetics2
Biotechnology2
ALS1
orphan disease1
Biopharma1
drug development1
epilepsy1
genetics1
Pharmaceutical1
ion channels1
neurology1
rare disease1
drug discovery1
Medical1
CNS1
Tauopathies1
Huntington's Disease1
Gene Therapy1
Neuropharmacology1

Funding rounds participated in

$35M sweet spot round size

Most of their 2 investments are in rounds between $30M and $39M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurology
Health Care
CNS
Pharmaceutical
Movement Disorders
Endocrinology

Date founded

1992

Investments made

V

Voyager Therapeutics, Inc. raised $39M on January 9, 2023

Investors: Neurocrine Biosciences

X

Xenon Pharmaceuticals Inc. raised $30M on December 2, 2019

Investors: Neurocrine Biosciences

Funding rounds raised

Total raised

$10M

from 1 investors over 1 rounds

N

Neurocrine Biosciences raised $10M on December 17, 2009

Investors: Venrock

FAQ